Global Cancer Drug based on CAR-T Supply, Demand and Key Producers, 2023-2029

Description

The global Cancer Drug based on CAR-T market size is expected to reach $ 902 million by 2029, rising at a market growth of 4.8% CAGR during the forecast period (2023-2029).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

A type of treatment in which a patient's T cells (a type of immune system cell) are changed in the laboratory so they will attack cancer cells. T cells are taken from a patient’s blood. Then the gene for a special receptor that binds to a certain protein on the patient’s cancer cells is added to the T cells in the laboratory. The special receptor is called a chimeric antigen receptor (CAR). Large numbers of the CAR T cells are grown in the laboratory and given to the patient by infusion. CAR T-cell therapy is used to treat certain blood cancers, and it is being studied in the treatment of other types of cancer. Also called chimeric antigen receptor T-cell therapy.

This report studies the global Cancer Drug based on CAR-T demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Cancer Drug based on CAR-T, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cancer Drug based on CAR-T that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Cancer Drug based on CAR-T total market, 2018-2029, (USD Million)
Global Cancer Drug based on CAR-T total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Cancer Drug based on CAR-T total market, key domestic companies and share, (USD Million)
Global Cancer Drug based on CAR-T revenue by player and market share 2018-2023, (USD Million)
Global Cancer Drug based on CAR-T total market by Type, CAGR, 2018-2029, (USD Million)
Global Cancer Drug based on CAR-T total market by Application, CAGR, 2018-2029, (USD Million).

This reports profiles major players in the global Cancer Drug based on CAR-T market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Fosun Kite Biotechnology, Gilead Sciences, Novartis and Bristol-Myers Squibb, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Cancer Drug based on CAR-T market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Cancer Drug based on CAR-T Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Cancer Drug based on CAR-T Market, Segmentation by Type
    Allogeneic
    Autologous

Global Cancer Drug based on CAR-T Market, Segmentation by Application
    Hospital
    Pharmacy
    Other

Companies Profiled:
    Fosun Kite Biotechnology
    Gilead Sciences
    Novartis
    Bristol-Myers Squibb

Key Questions Answered
1. How big is the global Cancer Drug based on CAR-T market?
2. What is the demand of the global Cancer Drug based on CAR-T market?
3. What is the year over year growth of the global Cancer Drug based on CAR-T market?
4. What is the total value of the global Cancer Drug based on CAR-T market?
5. Who are the major players in the global Cancer Drug based on CAR-T market?

Table of Contents

1 Supply Summary
    1.1 Cancer Drug based on CAR-T Introduction
    1.2 World Cancer Drug based on CAR-T Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Cancer Drug based on CAR-T Total Market by Region (by Headquarter Location)
        1.3.1 World Cancer Drug based on CAR-T Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Cancer Drug based on CAR-T Market Size (2018-2029)
        1.3.3 China Cancer Drug based on CAR-T Market Size (2018-2029)
        1.3.4 Europe Cancer Drug based on CAR-T Market Size (2018-2029)
        1.3.5 Japan Cancer Drug based on CAR-T Market Size (2018-2029)
        1.3.6 South Korea Cancer Drug based on CAR-T Market Size (2018-2029)
        1.3.7 ASEAN Cancer Drug based on CAR-T Market Size (2018-2029)
        1.3.8 India Cancer Drug based on CAR-T Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Cancer Drug based on CAR-T Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Cancer Drug based on CAR-T Major Market Trends

2 Demand Summary
    2.1 World Cancer Drug based on CAR-T Consumption Value (2018-2029)
    2.2 World Cancer Drug based on CAR-T Consumption Value by Region
        2.2.1 World Cancer Drug based on CAR-T Consumption Value by Region (2018-2023)
        2.2.2 World Cancer Drug based on CAR-T Consumption Value Forecast by Region (2024-2029)
    2.3 United States Cancer Drug based on CAR-T Consumption Value (2018-2029)
    2.4 China Cancer Drug based on CAR-T Consumption Value (2018-2029)
    2.5 Europe Cancer Drug based on CAR-T Consumption Value (2018-2029)
    2.6 Japan Cancer Drug based on CAR-T Consumption Value (2018-2029)
    2.7 South Korea Cancer Drug based on CAR-T Consumption Value (2018-2029)
    2.8 ASEAN Cancer Drug based on CAR-T Consumption Value (2018-2029)
    2.9 India Cancer Drug based on CAR-T Consumption Value (2018-2029)

3 World Cancer Drug based on CAR-T Companies Competitive Analysis
    3.1 World Cancer Drug based on CAR-T Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Cancer Drug based on CAR-T Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Cancer Drug based on CAR-T in 2022
        3.2.3 Global Concentration Ratios (CR8) for Cancer Drug based on CAR-T in 2022
    3.3 Cancer Drug based on CAR-T Company Evaluation Quadrant
    3.4 Cancer Drug based on CAR-T Market: Overall Company Footprint Analysis
        3.4.1 Cancer Drug based on CAR-T Market: Region Footprint
        3.4.2 Cancer Drug based on CAR-T Market: Company Product Type Footprint
        3.4.3 Cancer Drug based on CAR-T Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Cancer Drug based on CAR-T Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Cancer Drug based on CAR-T Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Cancer Drug based on CAR-T Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Cancer Drug based on CAR-T Consumption Value Comparison
        4.2.1 United States VS China: Cancer Drug based on CAR-T Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Cancer Drug based on CAR-T Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Cancer Drug based on CAR-T Companies and Market Share, 2018-2023
        4.3.1 United States Based Cancer Drug based on CAR-T Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Cancer Drug based on CAR-T Revenue, (2018-2023)
    4.4 China Based Companies Cancer Drug based on CAR-T Revenue and Market Share, 2018-2023
        4.4.1 China Based Cancer Drug based on CAR-T Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Cancer Drug based on CAR-T Revenue, (2018-2023)
    4.5 Rest of World Based Cancer Drug based on CAR-T Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Cancer Drug based on CAR-T Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Cancer Drug based on CAR-T Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Cancer Drug based on CAR-T Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Allogeneic
        5.2.2 Autologous
    5.3 Market Segment by Type
        5.3.1 World Cancer Drug based on CAR-T Market Size by Type (2018-2023)
        5.3.2 World Cancer Drug based on CAR-T Market Size by Type (2024-2029)
        5.3.3 World Cancer Drug based on CAR-T Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Cancer Drug based on CAR-T Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Hospital
        6.2.2 Pharmacy
        6.2.3 Other
    6.3 Market Segment by Application
        6.3.1 World Cancer Drug based on CAR-T Market Size by Application (2018-2023)
        6.3.2 World Cancer Drug based on CAR-T Market Size by Application (2024-2029)
        6.3.3 World Cancer Drug based on CAR-T Market Size by Application (2018-2029)

7 Company Profiles
    7.1 Fosun Kite Biotechnology
        7.1.1 Fosun Kite Biotechnology Details
        7.1.2 Fosun Kite Biotechnology Major Business
        7.1.3 Fosun Kite Biotechnology Cancer Drug based on CAR-T Product and Services
        7.1.4 Fosun Kite Biotechnology Cancer Drug based on CAR-T Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 Fosun Kite Biotechnology Recent Developments/Updates
        7.1.6 Fosun Kite Biotechnology Competitive Strengths & Weaknesses
    7.2 Gilead Sciences
        7.2.1 Gilead Sciences Details
        7.2.2 Gilead Sciences Major Business
        7.2.3 Gilead Sciences Cancer Drug based on CAR-T Product and Services
        7.2.4 Gilead Sciences Cancer Drug based on CAR-T Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Gilead Sciences Recent Developments/Updates
        7.2.6 Gilead Sciences Competitive Strengths & Weaknesses
    7.3 Novartis
        7.3.1 Novartis Details
        7.3.2 Novartis Major Business
        7.3.3 Novartis Cancer Drug based on CAR-T Product and Services
        7.3.4 Novartis Cancer Drug based on CAR-T Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Novartis Recent Developments/Updates
        7.3.6 Novartis Competitive Strengths & Weaknesses
    7.4 Bristol-Myers Squibb
        7.4.1 Bristol-Myers Squibb Details
        7.4.2 Bristol-Myers Squibb Major Business
        7.4.3 Bristol-Myers Squibb Cancer Drug based on CAR-T Product and Services
        7.4.4 Bristol-Myers Squibb Cancer Drug based on CAR-T Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 Bristol-Myers Squibb Recent Developments/Updates
        7.4.6 Bristol-Myers Squibb Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Cancer Drug based on CAR-T Industry Chain
    8.2 Cancer Drug based on CAR-T Upstream Analysis
    8.3 Cancer Drug based on CAR-T Midstream Analysis
    8.4 Cancer Drug based on CAR-T Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Cancer Drug based on CAR-T Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Cancer Drug based on CAR-T Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Cancer Drug based on CAR-T Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Cancer Drug based on CAR-T Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Cancer Drug based on CAR-T Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Cancer Drug based on CAR-T Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Cancer Drug based on CAR-T Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Cancer Drug based on CAR-T Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Cancer Drug based on CAR-T Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Cancer Drug based on CAR-T Players in 2022
    Table 12. World Cancer Drug based on CAR-T Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Cancer Drug based on CAR-T Company Evaluation Quadrant
    Table 14. Head Office of Key Cancer Drug based on CAR-T Player
    Table 15. Cancer Drug based on CAR-T Market: Company Product Type Footprint
    Table 16. Cancer Drug based on CAR-T Market: Company Product Application Footprint
    Table 17. Cancer Drug based on CAR-T Mergers & Acquisitions Activity
    Table 18. United States VS China Cancer Drug based on CAR-T Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Cancer Drug based on CAR-T Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Cancer Drug based on CAR-T Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Cancer Drug based on CAR-T Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Cancer Drug based on CAR-T Revenue Market Share (2018-2023)
    Table 23. China Based Cancer Drug based on CAR-T Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Cancer Drug based on CAR-T Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Cancer Drug based on CAR-T Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Cancer Drug based on CAR-T Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Cancer Drug based on CAR-T Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Cancer Drug based on CAR-T Revenue Market Share (2018-2023)
    Table 29. World Cancer Drug based on CAR-T Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Cancer Drug based on CAR-T Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Cancer Drug based on CAR-T Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Cancer Drug based on CAR-T Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Cancer Drug based on CAR-T Market Size by Application (2018-2023) & (USD Million)
    Table 34. World Cancer Drug based on CAR-T Market Size by Application (2024-2029) & (USD Million)
    Table 35. Fosun Kite Biotechnology Basic Information, Area Served and Competitors
    Table 36. Fosun Kite Biotechnology Major Business
    Table 37. Fosun Kite Biotechnology Cancer Drug based on CAR-T Product and Services
    Table 38. Fosun Kite Biotechnology Cancer Drug based on CAR-T Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. Fosun Kite Biotechnology Recent Developments/Updates
    Table 40. Fosun Kite Biotechnology Competitive Strengths & Weaknesses
    Table 41. Gilead Sciences Basic Information, Area Served and Competitors
    Table 42. Gilead Sciences Major Business
    Table 43. Gilead Sciences Cancer Drug based on CAR-T Product and Services
    Table 44. Gilead Sciences Cancer Drug based on CAR-T Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Gilead Sciences Recent Developments/Updates
    Table 46. Gilead Sciences Competitive Strengths & Weaknesses
    Table 47. Novartis Basic Information, Area Served and Competitors
    Table 48. Novartis Major Business
    Table 49. Novartis Cancer Drug based on CAR-T Product and Services
    Table 50. Novartis Cancer Drug based on CAR-T Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Novartis Recent Developments/Updates
    Table 52. Bristol-Myers Squibb Basic Information, Area Served and Competitors
    Table 53. Bristol-Myers Squibb Major Business
    Table 54. Bristol-Myers Squibb Cancer Drug based on CAR-T Product and Services
    Table 55. Bristol-Myers Squibb Cancer Drug based on CAR-T Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 56. Global Key Players of Cancer Drug based on CAR-T Upstream (Raw Materials)
    Table 57. Cancer Drug based on CAR-T Typical Customers
List of Figure
    Figure 1. Cancer Drug based on CAR-T Picture
    Figure 2. World Cancer Drug based on CAR-T Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Cancer Drug based on CAR-T Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Cancer Drug based on CAR-T Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Cancer Drug based on CAR-T Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Cancer Drug based on CAR-T Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Cancer Drug based on CAR-T Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Cancer Drug based on CAR-T Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Cancer Drug based on CAR-T Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Cancer Drug based on CAR-T Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Cancer Drug based on CAR-T Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Cancer Drug based on CAR-T Revenue (2018-2029) & (USD Million)
    Figure 13. Cancer Drug based on CAR-T Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Cancer Drug based on CAR-T Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Cancer Drug based on CAR-T Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Cancer Drug based on CAR-T Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Cancer Drug based on CAR-T Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Cancer Drug based on CAR-T Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Cancer Drug based on CAR-T Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Cancer Drug based on CAR-T Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Cancer Drug based on CAR-T Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Cancer Drug based on CAR-T Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Cancer Drug based on CAR-T by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Cancer Drug based on CAR-T Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Cancer Drug based on CAR-T Markets in 2022
    Figure 27. United States VS China: Cancer Drug based on CAR-T Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Cancer Drug based on CAR-T Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Cancer Drug based on CAR-T Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Cancer Drug based on CAR-T Market Size Market Share by Type in 2022
    Figure 31. Allogeneic
    Figure 32. Autologous
    Figure 33. World Cancer Drug based on CAR-T Market Size Market Share by Type (2018-2029)
    Figure 34. World Cancer Drug based on CAR-T Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 35. World Cancer Drug based on CAR-T Market Size Market Share by Application in 2022
    Figure 36. Hospital
    Figure 37. Pharmacy
    Figure 38. Other
    Figure 39. Cancer Drug based on CAR-T Industrial Chain
    Figure 40. Methodology
    Figure 41. Research Process and Data Source

Companies Mentioned

Fosun Kite Biotechnology
Gilead Sciences
Novartis
Bristol-Myers Squibb